Cargando…

Dickkopf-1: A Promising Target for Cancer Immunotherapy

Clinical studies in a range of cancers have detected elevated levels of the Wnt antagonist Dickkopf-1 (DKK1) in the serum or tumors of patients, and this was frequently associated with a poor prognosis. Our analysis of DKK1 gene profile using data from TCGA also proves the high expression of DKK1 in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chu, Hang Yin, Chen, Zihao, Wang, Luyao, Zhang, Zong-Kang, Tan, Xinhuan, Liu, Shuangshuang, Zhang, Bao-Ting, Lu, Aiping, Yu, Yuanyuan, Zhang, Ge
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8174842/ https://www.ncbi.nlm.nih.gov/pubmed/34093545 http://dx.doi.org/10.3389/fimmu.2021.658097

Ejemplares similares

Optimized Anchor-Modified Peptides Targeting Mutated RAS Are Promising Candidates for Immunotherapy
por: Baleeiro, Renato B., et al.
Publicado: (2022)

The Roles of Sclerostin in Immune System and the Applications of Aptamers in Immune-Related Research
por: Sun, Meiheng, et al.
Publicado: (2021)

The cGAS-STING Pathway: A Promising Immunotherapy Target
por: Ou, Liang, et al.
Publicado: (2021)

Cancer/testis antigens: promising immunotherapy targets for digestive tract cancers
por: Ai, Huihan, et al.
Publicado: (2023)

Connective Tissue Growth Factor: From Molecular Understandings to Drug Discovery
por: Chen, Zihao, et al.
Publicado: (2020)

Structural Biology for the Molecular Insight between Aptamers and Target Proteins
por: Zhang, Ning, et al.
Publicado: (2021)

The Promise of Targeting Hypoxia to Improve Cancer Immunotherapy: Mirage or Reality?
por: Janji, Bassam, et al.
Publicado: (2022)

Promising Immunotherapy in Metastatic Testicular Sex Cord Stromal Tumours After First-Line Chemotherapy
por: Shang, Bingqing, et al.
Publicado: (2022)

Mannose Treatment: A Promising Novel Strategy to Suppress Inflammation
por: Zhang, Wei, et al.
Publicado: (2021)

Immunodiagnosis — the promise of personalized immunotherapy
por: Wang, Renjie, et al.
Publicado: (2023)

The Rise of NK Cell Checkpoints as Promising Therapeutic Targets in Cancer Immunotherapy
por: Sun, Haoyu, et al.
Publicado: (2019)

Dickkopf-3, a Tissue-Derived Modulator of Local T-Cell Responses
por: Meister, Michael, et al.
Publicado: (2015)

CD47 as a promising therapeutic target in oncology
por: Zhao, Hai, et al.
Publicado: (2022)

Promising immunotherapeutic targets in lung cancer based on single-cell RNA sequencing
por: Xue, Qianqian, et al.
Publicado: (2023)

Perspectives on Oncolytic Salmonella in Cancer Immunotherapy—A Promising Strategy
por: Wang, Ding, et al.
Publicado: (2021)

Effects of microenvironment in osteosarcoma on chemoresistance and the promise of immunotherapy as an osteosarcoma therapeutic modality
por: Yu, Lei, et al.
Publicado: (2022)

Artificial Intelligence in Aptamer–Target Binding Prediction
por: Chen, Zihao, et al.
Publicado: (2021)

Immunotherapy: a promising approach for glioma treatment
por: Yasinjan, Feroza, et al.
Publicado: (2023)

Immunotherapy: A promising novel endometriosis therapy
por: Li, Wenshu, et al.
Publicado: (2023)

Dickkopf-3 Contributes to the Regulation of Anti-Tumor Immune Responses by Mesenchymal Stem Cells
por: Lu, Kun-Hui, et al.
Publicado: (2015)

Promising New Tools for Targeting p53 Mutant Cancers: Humoral and Cell-Based Immunotherapies
por: Chasov, Vitaly, et al.
Publicado: (2021)

IGFBP7 and the Tumor Immune Landscape: A Novel Target for Immunotherapy in Bladder Cancer
por: Yi, Xianyanling, et al.
Publicado: (2022)

Listeria monocytogenes: a promising vector for tumor immunotherapy
por: Ding, Yi-Dan, et al.
Publicado: (2023)

Natural Killer Cell-Based Cancer Immunotherapies: From Immune Evasion to Promising Targeted Cellular Therapies
por: Hofer, Erhard, et al.
Publicado: (2017)

Current Immunotherapies for Glioblastoma Multiforme
por: Huang, Boyuan, et al.
Publicado: (2021)

Immunotherapy and Immunochemotherapy in Visceral Leishmaniasis: Promising Treatments for this Neglected Disease
por: Roatt, Bruno Mendes, et al.
Publicado: (2014)

The Promise of Personalized TCR-Based Cellular Immunotherapy for Cancer Patients
por: Arnaud, Marion, et al.
Publicado: (2021)

The role of tumor immune microenvironment in chordoma: promising immunotherapy strategies
por: Xu, Jiuhui, et al.
Publicado: (2023)

The promising immune checkpoint LAG-3 in cancer immunotherapy: from basic research to clinical application
por: Huo, Jin-Ling, et al.
Publicado: (2022)

Combination treatment of radiofrequency ablation and peptide neoantigen vaccination: Promising modality for future cancer immunotherapy
por: Shou, Jiawei, et al.
Publicado: (2022)

Treg: A Promising Immunotherapeutic Target in Oral Diseases
por: Zhang, Yujing, et al.
Publicado: (2021)

Revisiting targeted therapy and immunotherapy for advanced cholangiocarcinoma
por: Du, Jiajia, et al.
Publicado: (2023)

Checkpoint inhibitors as immunotherapy for fungal infections: Promises, challenges, and unanswered questions
por: Wurster, Sebastian, et al.
Publicado: (2022)

Cytokine release syndrome and cancer immunotherapies – historical challenges and promising futures
por: Shah, Deep, et al.
Publicado: (2023)

Focusing on NK cells and ADCC: A promising immunotherapy approach in targeted therapy for HER2-positive breast cancer
por: Li, Feifei, et al.
Publicado: (2022)

Heparins are potent inhibitors of ectonucleotide pyrophosphatase/phospho-diesterase-1 (NPP1) – a promising target for the immunotherapy of cancer
por: Lopez, Vittoria, et al.
Publicado: (2023)

Targeting Natural Killer Cells for Tumor Immunotherapy
por: Zhang, Cai, et al.
Publicado: (2020)

The Next Frontier of Regulatory T Cells: Promising Immunotherapy for Autoimmune Diseases and Organ Transplantations
por: Terry, Lauren V., et al.
Publicado: (2020)

Innovative and Promising Strategies to Enhance Effectiveness of Immunotherapy for CNS Tumors: Where Are We?
por: Quintarelli, Concetta, et al.
Publicado: (2021)

Advance in Targeted Immunotherapy for Graft-Versus-Host Disease
por: Zhang, Lingling, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5q1oh7k82ebtcj6ande7b0utmt